OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
Georgia Deliyannis, Nicholas A. Gherardin, Chinn Yi Wong, et al.
EBioMedicine (2023) Vol. 92, pp. 104574-104574
Open Access | Times Cited: 13
Georgia Deliyannis, Nicholas A. Gherardin, Chinn Yi Wong, et al.
EBioMedicine (2023) Vol. 92, pp. 104574-104574
Open Access | Times Cited: 13
Showing 13 citing articles:
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
A novel platform for engineered AAV-based vaccines
Sabrina Babutzka, Miranda Gehrke, Αναστασία Παπαδοπούλου, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101418-101418
Open Access
Sabrina Babutzka, Miranda Gehrke, Αναστασία Παπαδοπούλου, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101418-101418
Open Access
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling
Stefanie M. Bader, L.R. Scherer, Jan Schaefer, et al.
Cell Death and Differentiation (2025)
Open Access
Stefanie M. Bader, L.R. Scherer, Jan Schaefer, et al.
Cell Death and Differentiation (2025)
Open Access
Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine
Julio Carrera Montoya, Simon Collett, Daniel Fernandez‐Ruiz, et al.
Organoids (2024) Vol. 3, Iss. 1, pp. 18-31
Open Access | Times Cited: 4
Julio Carrera Montoya, Simon Collett, Daniel Fernandez‐Ruiz, et al.
Organoids (2024) Vol. 3, Iss. 1, pp. 18-31
Open Access | Times Cited: 4
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
Terry Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
EBioMedicine (2023) Vol. 98, pp. 104878-104878
Open Access | Times Cited: 10
Terry Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
EBioMedicine (2023) Vol. 98, pp. 104878-104878
Open Access | Times Cited: 10
Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
Simon Collett, Linda Earnest, Julio Carrera Montoya, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 7
Simon Collett, Linda Earnest, Julio Carrera Montoya, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 7
A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal Models
Chunyun Sun, Desheng Kong, Erhong Guo, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 526-526
Open Access | Times Cited: 5
Chunyun Sun, Desheng Kong, Erhong Guo, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 526-526
Open Access | Times Cited: 5
Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity
Guo-Qing Zou, Ke Li, Cheng Yan, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126145-126145
Closed Access | Times Cited: 1
Guo-Qing Zou, Ke Li, Cheng Yan, et al.
Vaccine (2024) Vol. 42, Iss. 21, pp. 126145-126145
Closed Access | Times Cited: 1
mRNA vaccines encoding membrane-anchored receptor-binding domains of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
Hareth Al-Wassiti, Stewart A. Fabb, Samantha L. Grimley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Hareth Al-Wassiti, Stewart A. Fabb, Samantha L. Grimley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
IMMUNOLOGICAL STORM AND MULTIPLE ORGAN DAMAGE BY COVID-19
A. Yaser Arafath, S. Aifa Fathima, Anushara Prabhakaran, et al.
Medicine in Omics (2024) Vol. 11, pp. 100034-100034
Open Access
A. Yaser Arafath, S. Aifa Fathima, Anushara Prabhakaran, et al.
Medicine in Omics (2024) Vol. 11, pp. 100034-100034
Open Access
mRNA vaccines encoding membrane-anchored receptor-binding domains of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
Hareth Al-Wassiti, Stewart A. Fabb, Samantha L. Grimley, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101380-101380
Open Access
Hareth Al-Wassiti, Stewart A. Fabb, Samantha L. Grimley, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101380-101380
Open Access
Enhancing COVID-19 Vaccine Efficacy: Dual Adjuvant Strategies with TLR7/8 Agonists and Glycolipids
Ke Li, Xing Hu, Xinyi Tu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Ke Li, Xing Hu, Xinyi Tu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Interim Results from a Phase I Trial of Novel SARS-CoV-2 Beta Variant Receptor-Binding Domain Recombinant Protein and mRNA Vaccines as a 4 <sup>th</sup> Dose Booster
Terry Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
(2023)
Closed Access | Times Cited: 1
Terry Nolan, Georgia Deliyannis, Maryanne Griffith, et al.
(2023)
Closed Access | Times Cited: 1
